Polyrizon Shares Flat After Delay in New Filing Near Highs
Polyrizon Ltd. ended Thursday mostly flat as the Israel-based biotech named a new board member. The update didn’t include trial results or financing. Shares last traded at $16.50, up a penny. During the session, the price moved between $17.165 and $16.17. Polyrizon is a micro-cap, with shares changing hands near the stock's 52-week high. The company has a market value around $29.5 million, according to Robinhood, with volume at 76,000 shares, higher than the 35,650 average. Its 52-week range is $2.88 to $18.20.